Finding simple solutions for developing countries
using advanced technology
|
Follow the links below to access scientific publications authored by Mintaka Scientists. Please note that in some cases free access to full text may not be available. Please do not hesitate to contact Mintaka for reprint requests. |
|
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide. H. Gaertner et al. Proc Natl Acad Sci U S A. 2008 Nov 11; 105(45): early edition article |
|
Chemokine Analogues Show Suitable Stability for Development as Microbicides. F. Cerini et al. J Acquir Immune Defic Syndr. 2008 Nov 4. [Epub ahead of print] |
|
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein. H. Gaertner et al. Bioconjug Chem. 2008 Feb;19(2):480-9. |
|
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4. H. Gaertner et al. Protein Eng Des Sel. 2008 Feb;21(2):65-72. |
|
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. M. M. Lederman et al. Science. 2004 Oct 15;306(5695):485-7 |
|
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. O. Hartley et al. Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16460-5 |
|
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. O .Hartley et al. J Virol. 2003 Jun;77(12):6637-44 |